文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛心脑血管急症

视神经脊髓炎谱系疾病相关中枢性呼吸衰竭的风险分层与呼吸机撤离

Risk Stratification and Ventilator Liberation in Neuromyelitis Optica Spectrum Disorder-Related Central Respiratory Failure.
PubMed 文献 · Neurocrit Care · 2026-03-12
一句话结论视神经脊髓炎谱系疾病患者中血小板淋巴细胞比值升高和延髓病灶是中枢性呼吸衰竭的独立预测因素,多数发生中枢性呼吸衰竭者仍可成功撤离呼吸机。

该回顾性队列纳入2020至2024年280例活动期视神经脊髓炎谱系疾病患者,其中28例(10.0%)发生中枢性呼吸衰竭,并与57例非中枢性呼吸衰竭对照匹配。多变量Cox回归显示血小板淋巴细胞比值升高(HR=1.003,95%CI 1.001-1.005,p=0.003)和MRI延髓病灶(HR=5.23,95%CI 2.03-13.45,p=0.001)为独立预测因素,列线图区分度良好(C-index=0.779)。28例中枢性呼吸衰竭患者中75.0%(21/28)成功撤离呼吸机(撤离>48小时),成功组糖皮质激素治疗时间更短且基线血小板淋巴细胞比值更高(均p<0.05);竞争风险模型显示血红蛋白升高为正面预测因素(sHR=1.02),而BMI升高(sHR=0.76)、AQP4-IgG阳性(sHR=0.39)和脓毒症(sHR=0.17)为独立负面预测因素。

要点

  • 视神经脊髓炎谱系疾病患者中枢性呼吸衰竭发生率为10.0%(28/280),MRI延髓病灶者风险显著升高(HR=5.23,95%CI 2.03-13.45)。
  • 血小板淋巴细胞比值每升高1单位,中枢性呼吸衰竭风险增加(HR=1.003,95%CI 1.001-1.005),列线图C-index=0.779可用于风险分层。
  • 发生中枢性呼吸衰竭者中75.0%(21/28)成功撤离呼吸机(撤离>48小时),成功组糖皮质激素治疗时间显著更短、基线血小板淋巴细胞比值更高(均p<0.05)。
  • 竞争风险模型显示血红蛋白升高为成功撤离的正面预测因素(sHR=1.02),BMI升高(sHR=0.76)、AQP4-IgG阳性(sHR=0.39)和脓毒症(sHR=0.17)为独立负面预测因素。

适用人群与场景

  • 2020至2024年收治的280例活动期视神经脊髓炎谱系疾病患者,其中28例发生中枢性呼吸衰竭并与57例非中枢性呼吸衰竭对照匹配(n=85)。
  • 中枢性呼吸衰竭定义为脑干或高位颈髓直接神经损伤导致的呼吸衰竭。

诊断标准与关键阈值

  • 中枢性呼吸衰竭定义:脑干或高位颈髓直接神经损伤导致的呼吸衰竭。
  • 成功撤离呼吸机定义:撤离>48小时。

处置流程与药物剂量

  • 在28例中枢性呼吸衰竭患者中,成功撤离呼吸机者糖皮质激素治疗时间显著短于失败者(p<0.05)。
  • 作者认为早期糖皮质激素治疗并监测BMI、AQP4-IgG状态和感染等预后因素可能指导临床管理。

研究设计与关键结果

  • 回顾性队列分析,280例活动期视神经脊髓炎谱系疾病患者中中枢性呼吸衰竭发生率为10.0%(28/280)。
  • 多变量Cox回归:血小板淋巴细胞比值升高(HR=1.003,95%CI 1.001-1.005,p=0.003)和MRI延髓病灶(HR=5.23,95%CI 2.03-13.45,p=0.001)为中枢性呼吸衰竭独立预测因素;列线图C-index=0.779。
  • 28例中枢性呼吸衰竭患者中75.0%(21/28)成功撤离呼吸机(撤离>48小时);成功组糖皮质激素治疗时间显著更短、基线血小板淋巴细胞比值显著更高(均p<0.05)。
  • 多变量竞争风险模型:血红蛋白升高为成功撤离的正面预测因素(sHR=1.02),BMI升高(sHR=0.76)、AQP4-IgG阳性(sHR=0.39)和脓毒症(sHR=0.17)为独立负面预测因素。

证据类型、等级与局限

  • 证据类型:回顾性队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对活动期视神经脊髓炎谱系疾病患者,可用血小板淋巴细胞比值和MRI延髓病灶识别中枢性呼吸衰竭高风险者(列线图C-index=0.779)。
  • 发生中枢性呼吸衰竭者多数仍可成功撤离呼吸机(75.0%,21/28),不应仅因此放弃撤离尝试。
  • 作者认为早期糖皮质激素治疗并监测BMI、AQP4-IgG状态和感染可能指导临床管理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: This study aimed to identify risk factors for central respiratory failure (CRF) in neuromyelitis optica spectrum disorder (NMOSD) and investigate predictors of successful mechanical ventilator liberation in affected patients.

METHODS: This retrospective cohort analysis included 280 active patients with NMOSD admitted between 2020 and 2024. CRF was defined as respiratory failure caused by direct neurological injury to the brainstem or high cervical spinal cord. Among these patients, 28 developed CRF and were matched with 57 non-CRF controls (n = 85). Multivariable Cox proportional hazards regression was used to identify independent CRF risk factors, and a nomogram was generated. Predictors of successful weaning (liberation > 48 h) were examined in the 28 patients with CRF using descriptive statistics and exploratory Fine-Gray competing risk analysis.

RESULTS: The incidence of CRF in NMOSD was 10.0% (28/280). Multivariable Cox analysis identified two independent predictors of CRF: elevated platelet-lymphocyte ratio (PLR) [hazard ratio (HR) = 1.003, 95% confidence interval (CI) 1.001-1.005; p = 0.003] and medullary lesion on magnetic resonance imaging (MRI) (HR = 5.23, 95% CI 2.03-13.45; p = 0.001). The nomogram showed good discrimination (C-index = 0.779) and enabled effective risk stratification. Among patients with CRF, 75.0% (21/28) achieved successful ventilator liberation. Patients who achieved successful weaning had a significantly shorter time to glucocorticoid treatment and higher baseline PLR than those who failed (both p < 0.05). In the multivariate competing risk model, higher hemoglobin subdistribution HR (sHR = 1.02) was a positive predictor, whereas higher body mass index (BMI) (sHR = 0.76), AQP4-IgG seropositivity (sHR = 0.39), and sepsis (sHR = 0.17) were independent negative predictors.

CONCLUSIONS: Elevated PLR and medullary lesions are independent risk factors for CRF in NMOSD, which can be predicted by the generated nomogram. Furthermore, successful ventilator liberation is achievable in most patients with CRF, and early glucocorticoid treatment alongside monitoring of prognostic factors such as BMI, AQP4-IgG status, and infection may guide clinical management.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Huang H, Liu Y, Li J, et al. Risk Stratification and Ventilator Liberation in Neuromyelitis Optica Spectrum Disorder-Related Central Respiratory Failure. Neurocrit Care. 2026. PMID: 41817834. doi:10.1007/s12028-026-02475-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。